The Safe Administration of Remdesivir in a Patient with Acute Kidney Injury Requiring Hemodialysis
Remdesivir is a nucleoside analog prodrug with broad-spectrum antiviral activity, including against coronaviruses. This has prioritized the inclusion of remdesivir in coronavirus disease 2019 (COVID-19) clinical trials. The United States Food and Drug Administration has granted emergency use authori...
Saved in:
| Main Authors: | Vincent Peyko, Helena Ladd, Anthony Cutrona |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2020/8811798 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury
by: Elise André, et al.
Published: (2024-01-01) -
Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated
by: Delma J. Nieves, et al.
Published: (2025-03-01) -
National Trends and Impact of Acute Kidney Injury Requiring Hemodialysis in Hospitalizations With Atrial Fibrillation
by: Lili Chan, et al.
Published: (2016-12-01) -
Vancomycin administration and AUC/MIC in patients with acute kidney injury on hemodialysis (HD): randomized clinical trial
by: Welder Zamoner, et al.
Published: (2024-12-01) -
Severe acute kidney injury with anuria induced by hypokalemia requiring hemodialysis: a case study
by: Seong-Wook Lee, et al.
Published: (2025-03-01)